Correlation Between Dynavax Technologies and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Neurocrine Biosciences, you can compare the effects of market volatilities on Dynavax Technologies and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Neurocrine Biosciences.
Diversification Opportunities for Dynavax Technologies and Neurocrine Biosciences
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dynavax and Neurocrine is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Neurocrine Biosciences
Given the investment horizon of 90 days Dynavax Technologies is expected to generate 0.39 times more return on investment than Neurocrine Biosciences. However, Dynavax Technologies is 2.57 times less risky than Neurocrine Biosciences. It trades about 0.09 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about -0.22 per unit of risk. If you would invest 1,245 in Dynavax Technologies on November 18, 2024 and sell it today you would earn a total of 37.00 from holding Dynavax Technologies or generate 2.97% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dynavax Technologies vs. Neurocrine Biosciences
Performance |
Timeline |
Dynavax Technologies |
Neurocrine Biosciences |
Dynavax Technologies and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dynavax Technologies and Neurocrine Biosciences
The main advantage of trading using opposite Dynavax Technologies and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |